Market Competition Analysis: FedEx vs. UPS
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 14 2026
0mins
Source: Fool
- Market Capital Comparison: Both FedEx and UPS have market caps around $83 billion, but UPS has seen a 40% decline over the past five years while FedEx's market cap has increased by 15%, highlighting a significant divergence that reflects a reassessment of UPS's value by the market.
- Business Restructuring Progress: UPS is undergoing a substantial business overhaul aimed at becoming a leaner and more agile company, shedding low-profit customers and assets, with expectations for a turnaround in the second half of 2026; if financial performance continues to improve, it may achieve a higher market valuation.
- Valuation Metrics Analysis: FedEx's price-to-sales ratio stands at 0.95 and its price-to-earnings ratio is nearly 20, while UPS has a price-to-sales ratio of 0.97 and a price-to-earnings ratio of 15; although UPS appears relatively cheap, its restructuring context may make it more appealing to value investors.
- Growth Potential Assessment: FedEx recently raised the low end of its fiscal 2026 guidance, indicating that its business is performing better than management initially expected, and despite UPS's restructuring phase, both companies remain competitively positioned in the long term due to the growth in e-commerce.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy UPS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on UPS
Wall Street analysts forecast UPS stock price to fall
19 Analyst Rating
9 Buy
9 Hold
1 Sell
Moderate Buy
Current: 107.240
Low
80.00
Averages
107.06
High
126.00
Current: 107.240
Low
80.00
Averages
107.06
High
126.00
About UPS
United Parcel Service, Inc. is a global package delivery and logistics provider. Its U.S. Domestic Package segment offers a full spectrum of air and ground package transportation services. Its air portfolio offers time-definite, same-day, next-day, two-day and three-day delivery alternatives as well as air cargo services. Its ground network enables customers to ship using its day-definite ground service. Ground Saver provides residential ground service for customers with non-urgent, lightweight residential shipments. Its International Package segment consists of small package operations in Europe, Middle East and Africa, Canada and Latin America and Asia. It offers a selection of guaranteed day and time-definite international transportation services supported by its brokerage capabilities that facilitate cross-border clearance for international shipments. Its supply chain solutions consist of customized third-party logistics and specialized cold chain transportation solutions.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
FedEx Projects 11% Revenue Growth Amid Operational Changes
- Revenue Growth Outlook: FedEx anticipates approximately 11% revenue growth for the upcoming year, with earnings per share projected between $16.90 and $18.10, reflecting strong financial performance bolstered by increased shipping rates.
- Fiscal Year Adjustment: The company is aligning its fiscal year with the calendar year, previously ending on May 31, aiming to enhance financial transparency and operational efficiency through this strategic shift.
- Impact of Business Spin-off: Following the spin-off of its freight trucking unit on June 1, FedEx reported an adjusted earnings per share of $6.31 for the quarter, up from $6.07 a year earlier, indicating the effectiveness of its operational streamlining efforts.
- Market Challenges and Opportunities: Despite challenges from changing U.S. trade policies affecting low-value e-commerce shipments from China, FedEx's core express segment saw a 14% revenue increase, highlighting its potential in the premium overnight delivery market.
See More
Ten Years Post-Brexit: Economic Impacts in the UK
- Market Volatility: SpaceX's deal with AI startup Reflection and a $20 billion bond sale failed to excite investors, leading to a 16% drop in shares yesterday and nearly a 24% loss over three days, indicating a lack of investor confidence.
- Oil Price Fluctuations: U.S. Treasury Secretary Scott Bessent announced a 60-day authorization for Iranian oil production and sales, but President Trump noted profits would be used for U.S. agricultural purchases, which an Iranian banker disputed, resulting in a drop in oil prices on Monday.
- Target's Confidence Crisis: Target's executive chairman Brian Cornell received only 87% support at the annual meeting, significantly below historical averages, raising concerns about his leadership, with some analysts labeling his position as a “reward for failure.”
- Lucid Layoffs: Lucid announced an 18% reduction in its U.S. workforce to cut costs, aiming for $158 million in annual savings, while operations chief Marc Winterhoff will leave the company, reflecting a tightening strategy amid market challenges.
See More
Ten Years Post-Brexit: Economic Changes in the UK
- SpaceX Stock Volatility: Following its Nasdaq listing, SpaceX's stock fell 16% on Monday after announcing a computing power deal with AI startup Reflection and a $20 billion bond sale, resulting in a nearly 24% loss over three days, indicating waning investor confidence.
- U.S. Treasury Policy Update: Treasury Secretary Scott Bessent announced a 60-day authorization for Iranian oil production and sales, with Trump suggesting profits would fund U.S. agricultural purchases, though an Iranian banker denied any obligation, leading to a drop in oil prices on Monday.
- Target Leadership Crisis: Target's Executive Chairman Brian Cornell received only 87% support at the annual meeting, significantly below historical averages, raising concerns about his leadership amid profit and stock declines, as noted by analysts.
- Lucid Layoff Announcement: Lucid revealed plans to cut 18% of its U.S. workforce to reduce costs, aiming for annual savings of approximately $158 million, while also eliminating the operations chief position, reflecting a tightening strategy under market pressures.
See More
UPS Invests $48 Million to Expand Temperature-Controlled Freight Network
- Investment Expansion: UPS announced a $48 million investment to expand its global network of temperature-controlled freight cross-dock facilities, aimed at meeting the growing demand for healthcare shipments, particularly for biopharmaceutical products.
- Facility Construction: The plan includes building 27 cross-dock facilities across key markets in the U.S., Europe, Asia, and the Americas, which will support short-term storage and transfers between air and ground transport while maintaining required temperature conditions for pharmaceuticals.
- Market Demand: According to industry estimates, demand for temperature-sensitive biologics is expected to grow at an annual rate of 8.3%, reaching approximately $39.1 billion by 2033, indicating a strong need for specialized cold-chain logistics.
- Compliance Standards: The new facilities will comply with IATA CEIV Pharma standards, aiming to reduce handling risks by limiting the number of handoffs between logistics providers, while continuous monitoring will track shipments to ensure timely responses to potential disruptions.
See More
UPS Invests $48 Million to Expand Cold-Chain Network for Healthcare Logistics
- Investment Scale: UPS announced a $48 million investment in 27 temperature-controlled freight cross-dock facilities globally, strategically located in key U.S. and international markets to enhance the efficiency and safety of transporting temperature-sensitive medicines, thereby addressing the growing demand in the biopharmaceutical sector.
- Market Demand: The industry demand for temperature-sensitive biologics is projected to grow at an 8.3% compound annual growth rate, reaching $39.1 billion, prompting UPS to strengthen its cold-chain logistics capabilities to ensure product quality and safety throughout the manufacturing to patient delivery process.
- Technological Advantage: All new facilities comply with IATA CEIV Pharma certification standards, and by integrating transportation modes, they reduce handoff risks between providers, enhancing real-time monitoring and intervention capabilities for high-value temperature-sensitive therapies, thereby mitigating potential cold-chain failure costs.
- Strategic Expansion: UPS's cross-dock expansion builds on its long-term investment in complex healthcare logistics, recently expanding its Incheon air hub in South Korea to support fast-growing pharmaceutical trade flows, further enhancing its competitiveness in the global market.
See More
UPS Invests $48 Million to Expand Cold Chain Logistics
- Cold Chain Investment: UPS has announced a $48 million investment in 27 temperature-controlled facilities aimed at enhancing its competitiveness in healthcare logistics to meet the surging demand for pharmaceuticals and biologics.
- Market Growth Potential: The demand for temperature-sensitive biologics is projected to grow at an 8.3% compound annual growth rate, reaching a market value of approximately $39.1 billion by 2033, positioning UPS to capitalize on this rapidly expanding market with its investment.
- Enhanced Cold Chain Capabilities: UPS's global cross-dock facilities will strengthen its end-to-end cold chain capabilities, ensuring critical treatments are delivered safely and reliably to patients worldwide, reflecting the company's deep commitment to healthcare logistics.
- Revenue Growth Highlights: UPS's healthcare revenue surpassed $3 billion for the first time in Q1 2023, indicating a continuous increase in market share in this sector, further solidifying its position as an industry leader.
See More
FedEx Projects 11% Revenue Growth Amid Operational Changes
- Revenue Growth Outlook: FedEx anticipates approximately 11% revenue growth for the upcoming year, with earnings per share projected between $16.90 and $18.10, reflecting strong financial performance bolstered by increased shipping rates.
- Fiscal Year Adjustment: The company is aligning its fiscal year with the calendar year, previously ending on May 31, aiming to enhance financial transparency and operational efficiency through this strategic shift.
- Impact of Business Spin-off: Following the spin-off of its freight trucking unit on June 1, FedEx reported an adjusted earnings per share of $6.31 for the quarter, up from $6.07 a year earlier, indicating the effectiveness of its operational streamlining efforts.
- Market Challenges and Opportunities: Despite challenges from changing U.S. trade policies affecting low-value e-commerce shipments from China, FedEx's core express segment saw a 14% revenue increase, highlighting its potential in the premium overnight delivery market.
See More
Ten Years Post-Brexit: Economic Impacts in the UK
- Market Volatility: SpaceX's deal with AI startup Reflection and a $20 billion bond sale failed to excite investors, leading to a 16% drop in shares yesterday and nearly a 24% loss over three days, indicating a lack of investor confidence.
- Oil Price Fluctuations: U.S. Treasury Secretary Scott Bessent announced a 60-day authorization for Iranian oil production and sales, but President Trump noted profits would be used for U.S. agricultural purchases, which an Iranian banker disputed, resulting in a drop in oil prices on Monday.
- Target's Confidence Crisis: Target's executive chairman Brian Cornell received only 87% support at the annual meeting, significantly below historical averages, raising concerns about his leadership, with some analysts labeling his position as a “reward for failure.”
- Lucid Layoffs: Lucid announced an 18% reduction in its U.S. workforce to cut costs, aiming for $158 million in annual savings, while operations chief Marc Winterhoff will leave the company, reflecting a tightening strategy amid market challenges.
See More
Ten Years Post-Brexit: Economic Changes in the UK
- SpaceX Stock Volatility: Following its Nasdaq listing, SpaceX's stock fell 16% on Monday after announcing a computing power deal with AI startup Reflection and a $20 billion bond sale, resulting in a nearly 24% loss over three days, indicating waning investor confidence.
- U.S. Treasury Policy Update: Treasury Secretary Scott Bessent announced a 60-day authorization for Iranian oil production and sales, with Trump suggesting profits would fund U.S. agricultural purchases, though an Iranian banker denied any obligation, leading to a drop in oil prices on Monday.
- Target Leadership Crisis: Target's Executive Chairman Brian Cornell received only 87% support at the annual meeting, significantly below historical averages, raising concerns about his leadership amid profit and stock declines, as noted by analysts.
- Lucid Layoff Announcement: Lucid revealed plans to cut 18% of its U.S. workforce to reduce costs, aiming for annual savings of approximately $158 million, while also eliminating the operations chief position, reflecting a tightening strategy under market pressures.
See More
UPS Invests $48 Million to Expand Temperature-Controlled Freight Network
- Investment Expansion: UPS announced a $48 million investment to expand its global network of temperature-controlled freight cross-dock facilities, aimed at meeting the growing demand for healthcare shipments, particularly for biopharmaceutical products.
- Facility Construction: The plan includes building 27 cross-dock facilities across key markets in the U.S., Europe, Asia, and the Americas, which will support short-term storage and transfers between air and ground transport while maintaining required temperature conditions for pharmaceuticals.
- Market Demand: According to industry estimates, demand for temperature-sensitive biologics is expected to grow at an annual rate of 8.3%, reaching approximately $39.1 billion by 2033, indicating a strong need for specialized cold-chain logistics.
- Compliance Standards: The new facilities will comply with IATA CEIV Pharma standards, aiming to reduce handling risks by limiting the number of handoffs between logistics providers, while continuous monitoring will track shipments to ensure timely responses to potential disruptions.
See More
UPS Invests $48 Million to Expand Cold-Chain Network for Healthcare Logistics
- Investment Scale: UPS announced a $48 million investment in 27 temperature-controlled freight cross-dock facilities globally, strategically located in key U.S. and international markets to enhance the efficiency and safety of transporting temperature-sensitive medicines, thereby addressing the growing demand in the biopharmaceutical sector.
- Market Demand: The industry demand for temperature-sensitive biologics is projected to grow at an 8.3% compound annual growth rate, reaching $39.1 billion, prompting UPS to strengthen its cold-chain logistics capabilities to ensure product quality and safety throughout the manufacturing to patient delivery process.
- Technological Advantage: All new facilities comply with IATA CEIV Pharma certification standards, and by integrating transportation modes, they reduce handoff risks between providers, enhancing real-time monitoring and intervention capabilities for high-value temperature-sensitive therapies, thereby mitigating potential cold-chain failure costs.
- Strategic Expansion: UPS's cross-dock expansion builds on its long-term investment in complex healthcare logistics, recently expanding its Incheon air hub in South Korea to support fast-growing pharmaceutical trade flows, further enhancing its competitiveness in the global market.
See More
UPS Invests $48 Million to Expand Cold Chain Logistics
- Cold Chain Investment: UPS has announced a $48 million investment in 27 temperature-controlled facilities aimed at enhancing its competitiveness in healthcare logistics to meet the surging demand for pharmaceuticals and biologics.
- Market Growth Potential: The demand for temperature-sensitive biologics is projected to grow at an 8.3% compound annual growth rate, reaching a market value of approximately $39.1 billion by 2033, positioning UPS to capitalize on this rapidly expanding market with its investment.
- Enhanced Cold Chain Capabilities: UPS's global cross-dock facilities will strengthen its end-to-end cold chain capabilities, ensuring critical treatments are delivered safely and reliably to patients worldwide, reflecting the company's deep commitment to healthcare logistics.
- Revenue Growth Highlights: UPS's healthcare revenue surpassed $3 billion for the first time in Q1 2023, indicating a continuous increase in market share in this sector, further solidifying its position as an industry leader.
See More
